Karolina Pierzynowska
Gdansk, PM 80308, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 104 publications
Prevention of appearance of severe Huntington's disease symptoms in the R6/1 mouse model by early administration of 4',5,7-trihydroxyisoflavone.
Journal: Journal of Huntington's disease
Published: July 25, 2026
Engineering Komagataella phaffii for secreted and surface-displayed production of SARS-CoV-2 receptor-binding domain and its immunogenicity evaluation.
Journal: Microbial cell factories
Published: May 12, 2026
Author Correction: TFEB, FOXO3 and TLR4 in resveratrol-induced autophagy in a mucopolysaccharidosis IIIB mouse model.
Journal: Experimental & molecular medicine
Published: March 18, 2026
Extensive transcriptomic changes in cellular and animal models of Huntington's disease depending on the length of CAG repeats in the exon 1 of the HTT gene.
Journal: Biochemical and biophysical research communications
Published: March 14, 2026
Genistein (5,7-dihydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one) Is Effective in Reducing Symptoms of Huntington's Disease in Females of the R6/1 Mouse Model.
Journal: Frontiers in bioscience (Landmark edition)
Published: March 12, 2026
Potential effects of genistein in preventing progressive loss of cognitive functions in wild-type mice.
Journal: Nutritional neuroscience
Published: March 05, 2026
The role of estrogen and its receptors in the regulation of ferroptosis and autophagy.
Journal: Molecular biology reports
Published: February 20, 2026
Mitochondrial morphology and mtDNA content in fibroblasts from patients with different types of mucopolysaccharidosis.
Journal: Acta biochimica Polonica
Published: February 03, 2026
Primer investigation of RIG-I-like receptors expression in virus infection with the acute character.
Primer investigation of RIG-I-like receptors expression in virus infection with the acute character.
Journal: Innate immunity
Published: November 14, 2025
Mucopolysaccharidoses-What Clinicians Need to Know: A Clinical, Biochemical, and Molecular Overview.
Mucopolysaccharidoses-What Clinicians Need to Know: A Clinical, Biochemical, and Molecular Overview.
Journal: Biomolecules
Published: September 04, 2025
The use of genistein and ambroxol may be an effective approach in correcting cellular dysfunctions of mucopolysaccharidosis-plus syndrome.
Journal: Mammalian genome : official journal of the International Mammalian Genome Society
Published: August 21, 2025
Iron Dysregulation in Neurodegeneration with Brain Iron Accumulation (NBIA): Links between Mutations Occurring in BPAN, PKAN, MPAN and PLAN Types and Iron Metabolism.
Journal: Molecular neurobiology
Published: April 26, 2025
Last Updated: 09/26/2026